Reducing cannabinoid abuse and preventing relapse by enhancing endogenous brain levels of kynurenic acid
Secci, Maria E.
Redhi, Godfrey H.
Panlilio, Leigh V.
Goldberg, Steven R.Note: Order does not necessarily reflect citation order of authors.
MetadataShow full item record
CitationJustinova, Z., P. Mascia, H. Wu, M. E. Secci, G. H. Redhi, L. V. Panlilio, M. Scherma, et al. 2013. “Reducing cannabinoid abuse and preventing relapse by enhancing endogenous brain levels of kynurenic acid.” Nature neuroscience 16 (11): 10.1038/nn.3540. doi:10.1038/nn.3540. http://dx.doi.org/10.1038/nn.3540.
AbstractIn the reward circuitry of the brain, alpha-7-nicotinic acetylcholine receptors (α7nAChRs) modulate effects of delta-9-tetrahydrocannabinol (THC), marijuana’s main psychoactive ingredient. Kynurenic acid (KYNA) is an endogenous negative allosteric modulator of α7nAChRs. Here we report that the kynurenine 3-monooxygenase (KMO) inhibitor Ro 61-8048 increases brain KYNA levels and attenuates cannabinoid-induced increases in extracellular dopamine in reward-related brain areas. In the self-administration model of drug abuse, Ro 61-8048 reduced the rewarding effects of THC and the synthetic cannabinoid WIN 55,212-2 in squirrel monkeys and rats, respectively, and it also prevented relapse to drug-seeking induced by re-exposure to cannabinoids or cannabinoid-associated cues. The effects of enhancing endogenous KYNA levels with Ro 61-8048 were prevented by positive allosteric modulators of α7nAChRs. Despite a clear need, there are currently no medications approved for treatment of marijuana dependence. Modulation of KYNA provides a novel pharmacological strategy for achieving abstinence from marijuana and preventing relapse.
Citable link to this pagehttp://nrs.harvard.edu/urn-3:HUL.InstRepos:12406984
- HMS Scholarly Articles